Structured evidence table for Sea Buckthorn Exercise Recovery Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sea Buckthorn Exercise Recovery Randomized Trial | Many nontraditional risk factors as well as biomarkers may be linked to the development of CVD in addition to traditional risk factors. | 3 | Chen Yumeng (2024) | Research progress of sea buckthorn ( Hippophae rhamnoides L. ) in prevention and treatment of cardiovascular disease |
| Sea Buckthorn Exercise Recovery Randomized Trial | A body of evidence indicates that patients with CVD are at an elevated risk of experiencing a decline in kidney function and the development of kidney disease. | 3 | Chen Yumeng (2024) | Research progress of sea buckthorn ( Hippophae rhamnoides L. ) in prevention and treatment of cardiovascular disease |
| Sea Buckthorn Exercise Recovery Randomized Trial | Among statins, simvastatin and atorvastatin are associated with a greater risk of rhabdomyolysis (). | 3 | Chen Yumeng (2024) | Research progress of sea buckthorn ( Hippophae rhamnoides L. ) in prevention and treatment of cardiovascular disease |
| Sea Buckthorn Exercise Recovery Randomized Trial | 1 2 3 4 5 6 7 Cardiovascular disease (CVD) has long been an important cause of harm to humans. | 3 | Chen Yumeng (2024) | Research progress of sea buckthorn ( Hippophae rhamnoides L. ) in prevention and treatment of cardiovascular disease |
Source documents